Potent inhibition of specific diadenosine polyphosphate hydrolases by suramin

FEBS Letters

Volumn 429, Issue 2, 1998, Pages 143-146

  Rotllan P ^a   Rodriguez Ferrer C R ^a   Asensio, A C ^a   Oaknin, S ^a  

^a UNIVERSIDAD DE LA LAGUNA   (Spain)

Author keywords

Diadenosine tetraphosphate; Diadenosine tetraphosphate (asymmetrical) hydrolase; Diadenosine triphosphate; Diadenosine triphosphate hydrolase; Rat brain; Suramin

Indexed keywords

SURAMIN;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BINDING COMPETITION; DIAGNOSTIC VALUE; DRUG BINDING; DRUG POTENCY; ENZYME INHIBITION; HYDROLYSIS; MALE; NONHUMAN; PHOSPHATE METABOLISM; PRIORITY JOURNAL; RAT;

ACID ANHYDRIDE HYDROLASES; ANIMALS; BRAIN; DINUCLEOSIDE PHOSPHATES; ENZYME INHIBITORS; HYDROLYSIS; MALE; NEOPLASM PROTEINS; PHOSPHODIESTERASE INHIBITORS; PHOSPHORIC DIESTER HYDROLASES; RATS; RATS, WISTAR; SURAMIN; TISSUE EXTRACTS;

ANIMALIA;

EID: 0032511168     PISSN: 00145793     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-5793(98)00579-1     Document Type: Article

References (25)

1. Baxi M.D., Vishwanatha J.K. J. Pharmacol. Toxicol. Methods. 33:1995;121-128.
2. Pintor J., Hoyle C.H.V., Gualix J., Miras-Portugal M.T. Neurosci. Res. Commun. 20:1997;69-78.
3. Jovanovic A., Alekseev A.E., Terzic A. Biochem. Pharmacol. 54:1997;219-225.
4. Ripoll C., Martin F., Rovira J.M., Pintor J., Miras-Portugal M.T., Soria B. Diabetes. 45:1996;1431-1434.
5. Vartanian A., Narovlyansky A., Amchenkova A., Turpaev K., Kisselev L. FEBS Lett. 381:1996;32-34.
6. Vartanian A., Prudovsky I., Suzuki H., Pra I.D., Kisselev L. FEBS Lett. 415:1997;160-162.
7. Guranowski, A. and Sillero, A. (1992) in: Ap4A and Other Dinucleoside Polyphosphates (McLennan, A.G., Ed.) pp. 81-133, CRC Press, Boca Ratón, FL.
8. Ramos A., Rotllán P. Biochim. Biophys. Acta. 1253:1995;103-111.
9. Barnes L.D., Garrison P.N., Siprashvili Z., Guranowski A., Robinson A.K., Ingram S.W., Croce C., Ohta M., Huebner K. Biochemistry. 35:1996;11529-11535.
10. Siprashvili Z., Sozzi G., Barnes L.D., McCue P., Robinson A.K., Eryomin V., Sard L., Tagliabue E., Greco A., Fusetti L., Schwartz G., Pierotti M.A., Croce C.M., Huebner K. Proc. Natl. Acad. Sci. USA. 94:1997;13771-13776.
11. Voogd T.E., Vansterkenburg E.L.M., Wilting J., Janssen L.H. Pharmacol. Rev. 45:1993;177-203.
12. Baghdiguian S., Fantini J. Cancer J. 10:1997;31-37.
13. Windscheif U. J. Pharm. Pharmacol. 48:1996;993-1011.
14. Mateo J., Rotllán P., Miras-Portugal M.T. Br. J. Pharmacol. 119:1996;1-2.
15. Wierzchowski J., Sierakowska H., Shugar D. Biochim. Biophys. Acta. 82:1985;109-115.
16. Rotllán P., Ramos A., Pintor J., Torres M., Miras-Portugal M.T. FEBS Lett. 280:1991;371-374.
17. García-Agúndez J.A., Cameselle J.C., Costas M.J., Günther M.A., Sillero A. Biochim. Biophys. Acta. 1073:1991;402-409.
18. McGuire J.J., Haile W.H. Arch. Biochem. Biophys. 335:1996;139-144.
19. Cadène M., Duranton J., North A., Si-Tahar M., Chignard M., Bieth J.G. J. Biol. Chem. 272:1997;9950-9955.
20. Ziganshin A.U., Ziganshina L.L., King B.F., Burnstock G. Pflügers Arch. Eur. J. Physiol. 429:1995;412-418.
21. La Rocca R.V., Stein C.A., Myers C.E. Cancer Cells. 2:1990;106-115.
22. Bojanowski K., Lelièvre S., Markovits J., Couprie J., Jacquemin-Sablin A., Kragh-Larsen A. Proc. Natl. Acad. Sci. USA. 89:1992;3025-3029.
23. Rotllán P., Miras-Portugal M.T. Eur. J. Biochem. 151:1985;365-371.
24. Lienhard G.E., Secemsky I.I. J. Biol. Chem. 248:1973;1121-1123.
25. Fantini J., Rognoni J., Roccabianca M., Pommier G., Marvaldi J.J. J. Biol. Chem. 264:1989;10282-10286.